Not Sure Which Protocol Is Right for You?

Take our 3-minute quiz and get a personalized peptide protocol with exact dosages and cycling — tailored to your goals and body.

✓ Free ✓ Private ✓ Science-backed
Start the Quiz →

PT-141 (Bremelanotide)

Approuvé par la FDA pour le trouble de l'excitation sexuelle féminine

4.5
2 avis
Rate This Peptide

Rating Breakdown

Regulatory Approval Status
5.0
CNS-Mediated (Non-Vascular)
5.0
Libido Enhancement
4.5
Sexual Function
4.5
Onset Speed
3.5
Safety & Side Effects
3.5

Aperçu

PT-141 (Bremelanotide) est un agoniste des récepteurs mélanocortiniques approuvé par la FDA pour le traitement du trouble du désir sexuel hypoactif (HSDD) chez les femmes préménopausées.

Key Information

Identity
Also Known As Bremelanotide; Vyleesi
Sequence Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
CAS Number 189691-06-3
Molecular Formula C50H68N14O10
Properties
Half-Life 2-3 hours
Administration subcutaneous injection
Dosage Range 1.75 mg as needed
Price Range $2.0–$20.0/mg
Handling & Storage
Storage Refrigerated 2-8C
Reconstitution Pre-filled auto-injector
Regulatory Status
US Status FDA-approved (Vyleesi)
Research Papers 5 indexed

Mechanism

Active les récepteurs mélanocortiniques dans le cerveau, en particulier le MC4R, afin d'augmenter le désir sexuel indépendamment du système vasculaire.

Benefits

  • Désir sexuel accru
  • Approuvé par la FDA pour le HSDD
  • À médiation cérébrale (non vasculaire)
  • Utilisation à la demande

Side Effects

  • Nausées (40%)
  • Rougeurs
  • Maux de tête
  • Assombrissement de la peau

Contraindications

  • Cardiovascular disease
  • Pregnancy

Evidence Summary

Approuvé par la FDA sur la base d'essais de phase 3 pour le trouble du désir sexuel hypoactif.

Research

Approuvé par la FDA sous le nom de Vyleesi sur la base d'essais de phase 3 montrant une amélioration significative du désir sexuel et de la détresse associée.

View Research

Safety

Approuvé par la FDA. Effets indésirables : nausées, bouffées de chaleur, céphalées.

Frequently Asked Questions About PT-141 (Bremelanotide)

What is PT-141 (Bremelanotide)?

PT-141 (Bremelanotide) is a research peptide also known as Bremelanotide; Vyleesi. Approuvé par la FDA pour le trouble de l'excitation sexuelle féminine It is studied for its potential therapeutic applications and is available from various research chemical vendors.

How does PT-141 (Bremelanotide) work?

Active les récepteurs mélanocortiniques dans le cerveau, en particulier le MC4R, afin d'augmenter le désir sexuel indépendamment du système vasculaire.

What is the recommended dosage for PT-141 (Bremelanotide)?

The commonly studied dosage range for PT-141 (Bremelanotide) is 1.75 mg as needed. Dosage protocols vary based on research objectives. Always consult published studies and start with conservative amounts. PT-141 (Bremelanotide) should only be used in controlled research settings.

Where can I buy PT-141 (Bremelanotide)?

PepsReview indexes PT-141 (Bremelanotide) pricing from multiple vendors. Check the Vendors tab above for a price comparison table showing cost per milligram, purity, COA status, and stock availability. Vendor reviews from real users are available on each vendor's profile page.

Is PT-141 (Bremelanotide) legal?

US regulatory status: FDA-approved (Vyleesi). The legal status of PT-141 (Bremelanotide) varies by jurisdiction. In most countries, it is sold as a research chemical, not for human consumption. Always verify the legal status in your country before purchasing.

What are the side effects of PT-141 (Bremelanotide)?

Reported side effects include: Nausées (40%), Rougeurs, Maux de tête, Assombrissement de la peau. Always review safety data and published studies before use.

Key Research Papers on PT-141 (Bremelanotide)

The following peer-reviewed studies and clinical trials are indexed in our research library for PT-141 (Bremelanotide). Each paper links to a detailed summary with key findings, study design, and publication metadata.

Vendor Price Comparison

Product Vendor Size Price $/mg Purity COA Stock Visit
PT-141 10mg 10.0mg $59.00 $5.90 99%+ In Stock Visit
PT-141 10mg 10.0mg $70.00 $7.00 99%+ Janoshik (7d) In Stock Visit

Recherche

5 research papers indexed

View Research

Write a Review

Rating Breakdown

Effectiveness
4.5
Overall
4.5
Value
4.0
Safety
3.5

Based on 2 avis.

Avis

FDA-approved and it works 2026-06-22
Hannah H. Top Reviewer

PT-141 (bremelanotide) restored my libido completely. The fact it's FDA-approved for HSDD is a major plus. Brain-mediated mechanism is different from vascular drugs - works on desire not just blood flow. On-demand use is convenient.

Effectiveness: 5/5 Safety: 4/5 Value: 4/5
Works differently than expected 2026-06-12
Tom V. Top Reviewer

PT-141 takes about 2 hours to kick in. The desire increase is real - not just physical. Nausea is the main side effect. FDA approval makes me feel safe. Better than PDE5 inhibitors for psychological ED.

Effectiveness: 4/5 Safety: 3/5 Value: 4/5